TGFB2 and hepatocellular carcinoma: GPC3 knockdown-mediated cell cycle inhibition could be recapitulated with the addition of human recombinant TGF-β2, suggesting the possible involvement of TGF-β2 in the growth inhibition of hepatocellular carcinoma cells [67].